Stock research
CELG-RI Bristol-Myers Squibb Company Ce
Healthcare • Drug Manufacturers - General
Bristol Myers Squibb Company (BMS) operates as a biopharmaceutical enterprise, managing the entire lifecycle of its therapeutic products, from initial discovery and development to manufacturing, marketing, and...…
Bristol Myers Squibb Company (BMS) operates as a biopharmaceutical enterprise, managing the entire lifecycle of its therapeutic products, from initial discovery and development to manufacturing, marketing, and distribution. Its diverse portfolio includes conventional small molecule drugs, advanced biologics (which are derived from biological processes), and specialized chimeric antigen receptor (CAR-T) cell therapies. The company was established in August 1933 and maintains its corporate headquarters in Princeton, New Jersey.
5Y change
-47.51%
Range high
$0.21
Congress · 90d
0
Insiders · 90d
0
Public signal layer
Who is disclosing activity in CELG-RI?
Price
Showing 5Y history. Source: FMP historical price full.
- Prev Close
- $0.08
- Day High
- $0.12
- Day Low
- $0.08
- 52w High
- $0.12
- 52w Low
- $0.08
- Volume
- 52
- Avg Volume
- Beta
- -0.5130871
* TTM/most recent where available
Company
- Ticker
- CELG-RI
- Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Country
- US
- CEO
- Christopher S. Boerner
- Employees
- 34100
- Website
- www.bms.com
Key Metrics
- Market Cap
- 166M
- P/E
- P/B
- P/S
- EV/EBITDA
- ROE
- Net Margin
- Div Yield
- FCF/Share
* TTM/most recent where available
DCF Valuation
Standard DCF
Levered DCF
Market Price
DCF vs Price (30D window)
Price uses last 30 days; DCF line holds latest value across the window.DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).